csirt@kutim:~/threat-intel/cve/CVE-2026-57583

Katalog CVE

CVSS 3.3 · Low EPSS 0,19%

Kerentanan Improper Control of Generation of Code ('Code Injection'). Skor CVSS 3.1 3.3 (Low) menurut github.com.

Deskripsi (NVD)

OpenZeppelin Contracts Wizard is a web application to interactively build a contract out of components from OpenZeppelin Contracts. Prior to @openzeppelin/wizard 0.10.11, @openzeppelin/wizard-cairo 3.0.1, @openzeppelin/wizard-stellar 0.6.2, and @openzeppelin/wizard-stylus 0.3.1, the setInfo code path prints info.securityContact and info.license verbatim into single-line comments in generated Solidity, Cairo, Stellar/Soroban, and Stylus source. A line terminator ends the comment and causes following input to be emitted as source declarations. Exploitation requires an integration to populate these fields from untrusted input and a user to consume the generated source; normal self-service web, AI assistant, CLI, and self-hosted API use does not cross that trust boundary, shared links cannot set the fields, and no code executes on a Wizard service. This issue affects generated-source integrity only and is fixed in versions 0.10.11, 3.0.1, 0.6.2, and 0.3.1 of the respective packages.

Rincian

Terbit di NVD
14 September 2026
Terakhir diubah
30 September 2026
Status NVD
Deferred
CVSS 3.1
3.3 (Low), sumber github.com
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-94: Improper Control of Generation of Code ('Code Injection')
CWE-116: Improper Encoding or Escaping of Output
EPSS (30 hari)
0,19% peluang dieksploitasi; lebih tinggi dari 7,7% CVE lain

Produk dan versi terdampak

NVD belum mencantumkan data produk (CPE) untuk CVE ini. Produk yang terdampak biasanya disebut di deskripsi dan di advisory vendor pada daftar referensi.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:11 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.